MLLT6 Peptide - C-terminal region

Aviva Systems Biology

MLLT6 Peptide - C-terminal region

23

Research Use Only

Lyophilized powder

MLLT6

MLLT6, PHD finger containing

AF17, protein AF-17, ALL1-fused gene from chromosome 17 protein, KMT2A-MLLT6 fusion protein, KMT2A/MLLT6 fusion, MLLT6, PHD finger domain containing, MLLT6/KMT2A fusion, Myeloid/lymphoid or mixed-lineage leukemia, translocated to, 6, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog); translocated to, 6, myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6, myeloid/lymphoid or mixed-lineage leukemia; translocated to, 6, trithorax homolog

This is a synthetic peptide designed for use in combination with anti-AF17 Antibody (ARP34228_P050), made by Aviva Systems Biology. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications. Please inquire for more details.

-20°C

41116100

Human